Table 3 Age and gender of patients tested with LumiraDx SARS-CoV-2 Ag Test and a PCR-based method
From: Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19
Gender | Patient age, n (%) | ||||||
|---|---|---|---|---|---|---|---|
0–17 | 18–29 | 30–39 | 40–49 | 50–59 | >60 | Total | |
Male Female | 18 (5.3) 16 (3.5) | 98 (29.1) 34 (7.3) | 56 (16.6) 84 (18.1) | 43 (12.8) 117 (25.3) | 58 (17.2) 118 (25.5) | 64 (19.0) 64 (20.3) | 337 (100) 463 (100) |
800 | |||||||